Verition Fund Management’s Zurn Elkay Water Solutions ZWS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.51M | Sell |
69,443
-182,804
| -72% | -$8.94M | 0.02% | 832 |
|
|
2026
Q1 | $11.3M | Buy |
252,247
+81,975
| +48% | +$3.92M | 0.07% | 284 |
|
|
2025
Q4 | $7.92M | Sell |
170,272
-38,287
| -18% | -$1.8M | 0.03% | 591 |
|
|
2025
Q3 | $9.81M | Sell |
208,559
-242,995
| -54% | -$10.5M | 0.04% | 530 |
|
|
2025
Q2 | $16.5M | Buy |
451,554
+243,659
| +117% | +$8.39M | 0.07% | 299 |
|
|
2025
Q1 | $6.86M | Buy |
207,895
+100,311
| +93% | +$3.61M | 0.03% | 645 |
|
|
2024
Q4 | $4.01M | Buy |
107,584
+32,154
| +43% | +$1.23M | 0.02% | 1046 |
|
|
2024
Q3 | $2.71M | Buy |
75,430
+30,337
| +67% | +$960K | 0.01% | 1230 |
|
|
2024
Q2 | $1.33M | Buy |
45,093
+28,573
| +173% | +$900K | 0.01% | 1509 |
|
|
2024
Q1 | $553K | Sell |
16,520
-2,107
| -11% | -$64.9K | ﹤0.01% | 1957 |
|
|
2023
Q4 | $548K | Buy |
18,627
+6,275
| +51% | +$178K | ﹤0.01% | 1482 |
|
|
2023
Q3 | $346K | Sell |
12,352
-3,477
| -22% | -$99.4K | ﹤0.01% | 1641 |
|
|
2023
Q2 | $426K | Sell |
15,829
-285,322
| -95% | -$6.5M | 0.01% | 1328 |
|
|
2023
Q1 | $6.43M | Buy |
301,151
+268,688
| +828% | +$5.91M | 0.09% | 293 |
|
|
2022
Q4 | $687K | Sell |
32,463
-50,020
| -61% | -$1.18M | 0.01% | 1094 |
|
|
2022
Q3 | $2.02M | Sell |
82,483
-139,920
| -63% | -$3.99M | 0.02% | 891 |
|
|
2022
Q2 | $6.06M | Buy |
222,403
+124,937
| +128% | +$3.79M | 0.12% | 210 |
|
|
2022
Q1 | $3.45M | Sell |
97,466
-3,529
| -3% | -$117K | 0.04% | 596 |
|
|
2021
Q4 | $3.68M | Buy |
+100,995
| New | +$3.64M | 0.03% | 520 |
|
|
2021
Q2 | – | Sell |
-218,543
| Closed | -$4.96M | – | 2185 |
|
|
2021
Q1 | $4.96M | Buy |
+218,543
| New | +$4.69M | 0.06% | 203 |
|
|
2020
Q1 | – | Sell |
-37,775
| Closed | -$594K | – | 1111 |
|
|
2019
Q4 | $594K | Buy |
37,775
+21,659
| +134% | +$311K | 0.01% | 613 |
|
|
2019
Q3 | $210K | Sell |
16,116
-6,363
| -28% | -$85.1K | 0.01% | 937 |
|
|
2019
Q2 | $327K | Sell |
22,479
-36,116
| -62% | -$486K | 0.01% | 813 |
|
|
2019
Q1 | $710K | Buy |
58,595
+7,912
| +16% | +$98.4K | 0.03% | 528 |
|
|
2018
Q4 | $560K | Buy |
+50,683
| New | +$657K | 0.04% | 422 |
|
|
2018
Q3 | – | Sell |
-42,656
| Closed | -$597K | – | 1473 |
|
|
2018
Q2 | $597K | Buy |
+42,656
| New | +$603K | 0.04% | 619 |
|
|
2018
Q1 | – | Sell |
-25,252
| Closed | -$317K | – | 1344 |
|
|
2017
Q4 | $317K | Buy |
+25,252
| New | +$304K | 0.03% | 650 |
|
|
2017
Q3 | – | Sell |
-43,469
| Closed | -$487K | – | 1413 |
|
|
2017
Q2 | $487K | Buy |
43,469
+1,330
| +3% | +$14.9K | 0.05% | 433 |
|
|
2017
Q1 | $468K | Buy |
+42,139
| New | +$454K | 0.04% | 602 |
|
|
2016
Q4 | – | Sell |
-22,238
| Closed | -$229K | – | 1456 |
|
|
2016
Q3 | $229K | Buy |
+22,238
| New | +$225K | 0.02% | 917 |
|
Other funds holding ZWS
BMO
JT
Verition Fund Management's ZWS Position: Q2 2026 in Review
Verition Fund Management reduced its Zurn Elkay Water Solutions (ZWS) stake by 72% in Q2 2026, selling an estimated $8.94M and leaving 69,443 shares worth $3.51M. The position accounts for 0.02% of the portfolio, ranked #832.
Verition Fund Management first reported a position in ZWS in Q3 2016 and has held it in 30 quarters since. The position peaked at $16.5M in Q2 2025. 435 funds tracked by Wall St. Rank hold ZWS as of Q2 2026.
- Verition Fund Management held 69,443 shares of Zurn Elkay Water Solutions worth $3.51M as of Q2 2026.
- Verition Fund Management sold 182,804 Zurn Elkay Water Solutions shares in Q2 2026, an estimated $8.94M.
- Zurn Elkay Water Solutions made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #832 holding.
- Verition Fund Management first reported a position in Zurn Elkay Water Solutions in Q3 2016 and has held it in 30 quarters since.
- Verition Fund Management's Zurn Elkay Water Solutions position peaked at $16.5M in Q2 2025.
- 435 funds tracked by Wall St. Rank held Zurn Elkay Water Solutions as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.